Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

Cited by papers we hold 5

• Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease · 2019
  No notice
• WNT Signaling in Disease · 2019
  No notice
• Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL · 2012
  No notice
• Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease · 2012
  No notice
• A Wnt1 regulated Frizzled-1/β-Cateninsignaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.